A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Financial Summary
| Share Statistics | OPTH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $27.6 | $579.1 | 12% |
|
| Shares Out (Mil) | 2.3 | 43.0 | 8% |
|
| Institutional Ownership | 11.3% | 84.3% | 8% |
|
| Float (Mil) | 4.3 | 46.8 | 11% |
|
| Beta | 1.60 | 0.62 | 85% |
|
| Avg Daily Volume (000s) | 25 | 285 | 22% |
|
| Price Change (52-week) |
43.8% | 63.8% | 77% |
|
| Growth | OPTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | (93.3%) | (1.4%) | 2% |
|
| EPS (5yr) | 0.1% | 14.9% | 31 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (60.3%) | (14.9%) | 4% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | OPTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $272 | 0% |
|
| Net Income (TTM) (Mil) | ($4) | ($11) | 34% |
|
| EPS (TTM) | ($1.201) | ($0.500) | 20% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | ($6) | 28% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $4 | 43% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $7 | 10% |
|
| Enterprise Value (Q1) (Mil) | $32 | $522 | 13% |
|
| Valuation | OPTH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.11 | 2.73 | 82% |
|
| P/E | na | 20.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | OPTH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (83.2%) | 65.9% | 2% |
|
| Net Margin | na | 0.7% | na |
|
| ROA | (40.3%) | (24.6%) | 14% |
|
| ROE | (90.6%) | (19.7%) | 10% |
|
| Liabilities to Assets | 73.8% | 35.5% | 69% |
|
| F-Score | 2 | 3 | 7% |
|
Optimi Health Corp. did not pass any screens on 7/31/2026.
